Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Baxter
Cantor Fitzgerald
Mallinckrodt
Argus Health
Colorcon
Johnson and Johnson
Healthtrust
Farmers Insurance
Chinese Patent Office

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,008,294

« Back to Dashboard

Summary for Patent: 5,008,294
Title: Methods of treating tumors with compositions of catecholic butanes
Abstract:The invention relates to methods useful in the treatment of benign, premalignant and malignant solid tumors, especially those of the skin comprising methods for the administration of pharmacologically active compositions containing catecholic butanes. The invention also relates to methods of preventing the occurence of tumors, and the use of catecholic butanes as a sunscreening agent. The preferred catecholic butane is nordihydroguaiaretic acid. The preferred methods of application of the compositions containing catecholic butanes are by topical application and intratumor injection.
Inventor(s): Neiss; Edward S. (Denver, CO), Allen; Larry M. (Golden, CO)
Assignee: Chemex Pharmaceuticals, Inc. (Denver, CO)
Application Number:07/057,481
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Drugs Protected by US Patent 5,008,294

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,008,294

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2099092 ➤ Subscribe
Australia 8172487 ➤ Subscribe
Canada 1334170 ➤ Subscribe
Germany 3775387 ➤ Subscribe
European Patent Office 0288534 ➤ Subscribe
European Patent Office 0297733 ➤ Subscribe
Australia 1736088 ➤ Subscribe
Australia 616641 ➤ Subscribe
Austria 70449 ➤ Subscribe
Spain 2020011 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Accenture
QuintilesIMS
Covington
Medtronic
Baxter
Healthtrust
Harvard Business School
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot